https://www.selleckchem.com/products/reversan.html
Survival analysis suggested that HYP works best for the mesenchymal subtype patients. Tumor infiltration analysis predicted that HYP may affect Treg and macrophage infiltration in vivo. Using expression pattern of GBM patients and HYP-induced DEGs we suggested Fedratinib as a complementary drug to HYP. Our study represents the response of U87 cell line to HYP, with analyses on survival, transcription factors and personalization according to GBM subtype. Our study represents the response of U87 cell line to HYP, with analyses on surviva
Synes godt om
Kommentar
Del
